A Shanghai-developed COVID-19 mRNA vaccine has been approved for clinical trials by China's Center for Drug Evaluation. With volunteers for the first phase of trials now selected, manufacturers are gearing up for production.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3